MEROVA Health has secured 100 million HUF in funding to advance its AI-based diabetes prevention and management solutions.

Information on the Target

MEROVA Health has reached another significant milestone as a digital pioneer in diabetes prevention by securing a total capital investment of 100 million HUF in a new funding round. The investment includes 50 million HUF from Hiventures and 35 million HUF from Obuda Uni Venture Capital (OUVC), alongside contributions from the First Central European Hardware Accelerator and Szakacsits Ventures. This fresh capital will facilitate the development of their AI-based patient application, MEROVA – Zia, and the client management system, MEROVA – Anton, as well as the initiation of insurance pilot programs.

MEROVA addresses the needs of both patients and preventive healthcare providers. The Anton client management system offers a mobile-friendly tool for professionals, simplifying administration and creating personalized follow-up plans. These plans are taken into account by the patient-facing application, Zia, which assists patients in maintaining a healthy lifestyle.

Industry Overview in Hungary

The healthcare industry in Hungary is increasingly focusing on digital solutions that enhance patient outcomes, particularly in the management of chronic diseases such as diabetes. With diabetes-related complications causing significant healthcare costs a